SERIAL CREATINE KINASE-MB RESULTS ARE A SENSITIVE INDICATOR OF ACUTE MYOCARDIAL-INFARCTION IN CHEST PAIN PATIENTS WITH NONDIAGNOSTIC ELECTROCARDIOGRAMS - THE 2ND EMERGENCY-MEDICINE CARDIAC RESEARCH GROUP-STUDY
Gp. Young et al., SERIAL CREATINE KINASE-MB RESULTS ARE A SENSITIVE INDICATOR OF ACUTE MYOCARDIAL-INFARCTION IN CHEST PAIN PATIENTS WITH NONDIAGNOSTIC ELECTROCARDIOGRAMS - THE 2ND EMERGENCY-MEDICINE CARDIAC RESEARCH GROUP-STUDY, Academic emergency medicine, 4(9), 1997, pp. 869-877
Objective: To determine the test performance characteristics of serial
creatine kinase-MB (CK-MB) mass measurements for acute myocardial inf
arction (MI) in patients presenting to the ED with chest pain and nond
iagnostic ECGs. Methods: A prospective, observational test performance
study was conducted. Hemodynamically stable patients aged greater tha
n or equal to 25 years with chest discomfort, but without ECGs diagnos
tic for MI, were enrolled at 7 university teaching hospitals. Presenti
ng ECGs showing >1-mV ST-segment elevation in greater than or equal to
2 electrically contiguous leads were considered diagnostic for MI; pa
tients with diagnostic ECGs on presentation were excluded. Real-time,
serial CK-MB mass levels were obtained using a rapid serum immunochemi
cal assay at the time of ED presentation (0-hour) and 3 hours later (3
-hour). The following testing schemes were evaluated for their sensiti
vity and specificity for detection of MI during patient evaluation in
the ED: 1) an elevated (greater than or equal to 8 ng/mL) presenting C
K-MB level; 2) an elevated presenting and/or 3-hour CK-MB level; 3) a
significant increase (i.e., greater than or equal to 3 ng/mL) within t
he range of normal limits for CK-MB concentrations during the 3-hour p
eriod (Delta CK-MB); and/or 4) development of ST-segment elevation dur
ing the 3 hours (second ECG). Results: Of the 1,042 patients enrolled,
777 (74.6%) were hospitalized, including all 67 MI patients (8.6% of
admissions). As a function of duration of time in the ED, the test per
formance characteristics of serial CK-MBs for MI (and cumulative data
for the additional ECG) were: [GRAPHICS] The 0-hour to 3-hour CK-MB po
sitive and negative predictive values were 52% to 55% and 96% to 99%,
respectively. The sensitivities of serial CK-MB results as a function
of the interval following chest discomfort onset were: [GRAPHICS] Conc
lusion: Serial CK-MB monoclonal antibody mass measurements in the ED c
an identify MI patients with initially nondiagnostic ECGs. CK-MB sensi
tivity significantly increases over 3 hours of observation of stable c
hest discomfort patients in the ED; it also increases as a function of
the total interval from onset until enzyme measurement.